? CLINICAL TRANSLATIONAL CORE The Clinical/Translational Core provides an infrastructure and resources for human translational and patient- oriented research. This is accomplished in part by providing translational resources for liver investigators who are basic scientists, such as making bio-specimens available and offering iPSC?s/liver organoids derived from patients with specific diseases. The Core is useful for clinical researchers as well, who also make use of bio- specimens and our patient registry, plus the services of our research coordinator and statisticians. Therefore, the Clinical/Translational Core advances the science and practice of Hepatology through the following specific aims: (1) Provide resources necessary to support clinical and translational research, specifically: (a) biostatistical support, including study design and data analysis, with plans to increase expertise in database research, (b) bioinformatic support, including analysis and interpretation of whole-exome and whole-genome sequencing, RNA-seq, single cell RNA-seq, microRNA-seq, ChIP-seq, and 16S/18S and shotgun metagenomics, (c) patient registry and biospecimen repository, with recent extension of this repository to include peripheral blood mononuclear cells (PBMC) that can be transformed into iPSCs, as well as human bile, both of which can be used in the creation of liver organoids, and (d) staff support, including a research coordinator who can help locate/retrieve biospecimens from the liver center repository or from other relevant repositories at our institution, and a liver pathologist, who is available for consultation, retrieval and review of archived clinical specimens, and interpretation of other tissue specimens, such as from animal models. (2) Provide the environment in which high-quality clinical and translational research will be centered, thereby translating knowledge from basic science to clinical research, contributing to the development of young clinical investigators and creating collaborations among center members and other members of the scientific community interested in research relevant to liver. As a result of these efforts, half of the members who now use this core are laboratory- based investigators, and all center members who currently use this core collaborate with other center members.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK034989-36A1
Application #
10048272
Study Section
Special Emphasis Panel (ZDK1)
Project Start
1997-09-30
Project End
2025-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
36
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Yale University
Department
Type
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Brivio, Simone; Cadamuro, Massimiliano; Fabris, Luca et al. (2018) Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview. Gene Expr 18:31-50
Cox, Carly S; McKay, Sharen E; Holmbeck, Marissa A et al. (2018) Mitohormesis in Mice via Sustained Basal Activation of Mitochondrial and Antioxidant Signaling. Cell Metab 28:776-786.e5
Madiraju, Anila K; Qiu, Yang; Perry, Rachel J et al. (2018) Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo. Nat Med 24:1384-1394
Schmitz, Corinna; Noels, Heidi; El Bounkari, Omar et al. (2018) Mif-deficiency favors an atheroprotective autoantibody phenotype in atherosclerosis. FASEB J 32:4428-4443
Pan, Qiong; Zhang, Xiaoxun; Zhang, Liangjun et al. (2018) Solute Carrier Organic Anion Transporter Family Member 3A1 Is a Bile Acid Efflux Transporter in Cholestasis. Gastroenterology 155:1578-1592.e16
Jakab, Sofia Simona; Garcia-Tsao, Guadalupe (2018) Screening and Surveillance of Varices in Patients With Cirrhosis. Clin Gastroenterol Hepatol :
Fiorotto, Romina; Amenduni, Mariangela; Mariotti, Valeria et al. (2018) Src kinase inhibition reduces inflammatory and cytoskeletal changes in ?F508 human cholangiocytes and improves cystic fibrosis transmembrane conductance regulator correctors efficacy. Hepatology 67:972-988
Sari, Sinan; Dalgic, Buket; Muehlenbachs, Atis et al. (2018) Prototheca zopfii Colitis in Inherited CARD9 Deficiency. J Infect Dis 218:485-489
Yu, Dongke; Cai, Shi-Ying; Mennone, Albert et al. (2018) Cenicriviroc, a cytokine receptor antagonist, potentiates all-trans retinoic acid in reducing liver injury in cholestatic rodents. Liver Int 38:1128-1138
Garcia-Tsao, Guadalupe (2018) Regression of HCV cirrhosis: Time will tell. Hepatology 67:1651-1653

Showing the most recent 10 out of 763 publications